title: New oral nitric oxide-dependent medications for patients with coronary artery disease who have persistent angina pectoris.
authors.affiliation: Department of Medicine, Baruch Padeh Poria Medical Center, Faculty of Medicine in the Galilee Bar Ilan University, Lower Galilee, Israel.
authors.forename: Arnon
authors.initials: A
authors.lastname: Blum
mesh_terms: D000284:Administration, Oral; D060050:Angina, Stable / Q000188:drug therapy*; D003324:Coronary Artery Disease / Q000188:drug therapy*; D006801:Humans; D009569:Nitric Oxide / Q000378:metabolism*; D000069458:Ranolazine / Q000627:therapeutic use*; D026941:Sodium Channel Blockers / Q000627:therapeutic use*; D014292:Trimetazidine / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000627:therapeutic use*
chemical_list: D026941:Sodium Channel Blockers; D014665:Vasodilator Agents; D009569:Nitric Oxide; D000069458:Ranolazine; D014292:Trimetazidine